【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Overview 11
Therapeutics Development 12
Pipeline Products for Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Overview 12
Pipeline Products for Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Comparative Analysis 13
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics under Development by Companies 14
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics under Investigation by Universities/Institutes 17
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Products under Development by Companies 22
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Products under Investigation by Universities/Institutes 25
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Companies Involved in Therapeutics Development 26
AnGes MG, Inc. 26
AstraZeneca PLC 27
Bayer AG 28
Biosidus S.A. 29
Biscayne Pharmaceuticals, Inc. 30
Bristol-Myers Squibb Company 31
Cardiome Pharma Corp 32
CardioVascular BioTherapeutics, Inc. 33
Eagle Pharmaceuticals, Inc. 34
Gilead Sciences, Inc. 35
Hemostemix Ltd 36
Human Stem Cells Institute 37
Isis Pharmaceuticals, Inc. 38
Juventas Therapeutics, Inc. 39
Lacer, S.A. 40
Lee’s Pharmaceutical Holdings Limited 41
Lonestar Heart, Inc. 42
MedImmune, LLC 43
Merck & Co., Inc. 44
Miltenyi Biotec GmbH 45
Multi Gene Vascular Systems Ltd 46
Nuo Therapeutics, Inc. 47
Pluristem Therapeutics Inc. 48
Regado Biosciences, Inc. 49
The Medicines Company 50
ViroMed Co., Ltd. 51
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics Assessment 52
Assessment by Monotherapy Products 52
Assessment by Target 53
Assessment by Mechanism of Action 55
Assessment by Route of Administration 57
Assessment by Molecule Type 59
Drug Profiles 61
ACP-01 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
ALD-201 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
anacetrapib – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Aptamers for Cardiovascular Diseases – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
BAY-606583 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
beperminogene perplasmid – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
Biglycan Therapy for Cardiovascular Diseases – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
BIS-5409 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
bivalirudin – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
bivalirudin – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
BQ-123 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
C2 ceramide – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
C6 ceramide – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
cangrelor – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
CAP-1002 – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Cryocell – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
CVBT-141H – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
Gemacell – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Gene Therapy to Activate Vascular Endothelial Growth Factor for Cardiovascular Diseases – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
Gene Therapy to Activate VEGF for Ischemia – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
ISIS-APOARx – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
ISIS-CRPRx – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
JVS-100 – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
LA-419 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
MEDI-6012 – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
Monoclonal Antibody to Inhibit CD20 for Cardiovascular Disease – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
MultiGeneGraft – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
MZ-004 – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
Oligonucleotides for Ischemic Heart Disease and Duchenne Muscular Dystrophy – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
Proteins for Ischemic Heart Disease – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
ranolazine ER – Drug Profile 105
Product Description 105
Mechanism of Action 105
R&D Progress 105
rivaroxaban – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
Small Molecule for Coronary Artery Disease – Drug Profile 112
Product Description 112
Mechanism of Action 112
R&D Progress 112
Stem Cell Therapy for Cardiovascular Disease – Drug Profile 113
Product Description 113
Mechanism of Action 113
R&D Progress 113
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 115
Product Description 115
Mechanism of Action 115
R&D Progress 115
Synthetic Peptides to Modulate CD36 Receptor for Ischemic Heart Disease and Macular Degeneration – Drug Profile 117
Product Description 117
Mechanism of Action 117
R&D Progress 117
tirofiban hydrochloride – Drug Profile 119
Product Description 119
Mechanism of Action 119
R&D Progress 119
VM-202 – Drug Profile 121
Product Description 121
Mechanism of Action 121
R&D Progress 121
XL-652 – Drug Profile 123
Product Description 123
Mechanism of Action 123
R&D Progress 123
ZK-001 – Drug Profile 125
Product Description 125
Mechanism of Action 125
R&D Progress 125
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Recent Pipeline Updates 127
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Dormant Projects 155
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Discontinued Products 158
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Product Development Milestones 159
Featured News & Press Releases 159
Nov 14, 2014: The Medicines Company to Present New Data on Investigational Antiplatelet Agent Cangrelor at 2014 AHA Annual Scientific Sessions in Chicago 159
Oct 27, 2014: The Medicines Company Wins Favorable Judgment in Angiomax (Bivalirudin) Patent Litigation 159
Oct 06, 2014: Capricor Announces Plans to Pursue Clinical Program for the Treatment of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs) 160
Sep 02, 2014: Isis Pharmaceuticals Presents Data On ISIS-APO(A)RX At European Society of Cardiology Congress 2014 160
Jul 07, 2014: The Medicines Company Receives Market Authorization Renewal for Angiox (Bivalirudin) from the European Medicines Agency and the European Commission 161
Apr 28, 2014: The Medicines Company Files Petition Against Aurobindo Over Patent Infringement 162
Mar 30, 2014: Analysis of EUROMAX and HORIZONS-AMI Trials of The Medicines Company’s Angiomax Presented at ACC.14 162
Dec 23, 2013: European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Cangrelor 163
Oct 11, 2013: Medicure Announces Approval of Recommended Dosing Regimen for AGGRASTAT 164
Oct 09, 2013: First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax in Patients Undergoing Peripheral Endovascular Procedures 164
Appendix 166
Methodology 166
Coverage 166
Secondary Research 166
Primary Research 166
Expert Panel Validation 166
Contact Us 167
Disclaimer 167
【レポート販売概要】
■ タイトル：冠動脈疾患(CAD)(虚血性心疾患)の治療薬パイプライン動向（2015年上半期版）■ 英文：Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6034IDB
■ 調査対象地域：グローバル
- ビデオ監視の世界市場：システム（アナログ、IP）、構成品（カメラ、モニター、サーバー、ストレージデバイス、ソフトウェア）、サービス（VSaaS、メンテナンス）、用途、地域別分析The video surveillance market is expected to be worth USD 71.28 Billion by 2022, at an estimated CAGR of 16.56%. It holds a great potential across the commercial sector. This system is used to monitor the changing activities, changing information to protect, manage, and direct people. The commercial sector accounted for the largest share among all applications of the video surveillance market, fol …
- サージ保護デバイス（SPD）の世界市場分析：製品タイプ別（タイプ1、タイプ2、タイプ3、タイプ4）、定格別（0~50kA、50.1~100kA、100.1~200kA、200.1kA以上）、用途別、地域別、セグメント予測、2014 – 2025The global surge protection devices (SPDs) market is expected to reach USD 3.39 billion by 2025, according to a new study by Grand View Research, Inc. The high costs incurred due to electrical equipment downtime are expected to surge the demand for these devices over the forecast period.The need for protection against lightning and voltage fluctuations has triggered the implementation of SPDs. The …
- 装飾用塗料の世界市場About Decorative Paints and Coatings Market Decorative paints and coatings refer to any liquid surface covering applied on the interior or exterior structure of a building or an object for decorative or protective purpose. Decorative paints and coatings help prevent cracks, water seepage, fungus and algae, and enhance the beauty and life of the structure. The market covers product segments includi …
- 世界の非接触型決済市場（技術進歩、予測、分析）The increasing requirement of the consumers to make online payments and payments via mobile phones is helping the society tomove toward a cashless society. Financial institutions are offering various types of payment services tending people to use more of cards and mobile phones for payments. The potential marketing strategies provided by various business segment and payments market is changing th …
- Hadoopビッグデータ分析の世界市場予測（～2021）：構成要素別（ソリューション、サービス）、用途別、産業別、地域別The Hadoop big data analytics market is projected to grow from USD 6.71 Billion in 2016 to USD 40.69 Billion by 2021, at a CAGR of 43.4% during the forecast period. Growth in this market is mainly attributed to the increasing volume of big data and growing need for big data analytics. With increase in the volume of big data, companies are looking for ways to analyze and process it quickly and econ …
- 病院向け食品サービス装置の世界市場2017-2021About hospital foodservice equipmentThe hospital foodservice equipment market is a large market where the equipment is specifically designed to cater to the needs of in-patients and visitors coming to the hospital. The main aim of the foodservice department in the hospitals is to provide in-patients with nutritious meals so that they can recover faster. The foodservice department plans on differen …
- 世界のMake-up市場：M&A動向（2014年4月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global make-up market during April 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global make-up market throughout the month. Additionally, the report provides an overview of all the partnering …
- 自動車用OLEDの世界市場2017-2021ABSTRACTAbout Automotive OLED An OLED is a LED that emits light in response to an electric current. In an OLED, the emissive electroluminescent layer is a film of organic compounds, which is responsible for the emission of light on application of electricity. OLEDs are used to create digital displays in various electronic applications such as TV screens, PC monitors, mobile phones, and gaming cons …
- 韓国のIPTV市場Technavios market research analyst predicts the IPTV market in South Korea to grow steadily at a CAGR of around 5% during the forecast period. The rising fiber internet subscriptions and the increased demand for video-on-demand (VoD) are expected to drive the market growth over the next four years. The popularity of on-demand content, especially for TV genres such as live sports, reality shows, si …
- 世界における小型自動車用OE(メーカー純正部品)ガラス市場（2008-2028）This latest just-auto report edition offers a global review of the OE glazing sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE glazing market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Marke …
- 尿検査の世界市場：検尿ディップスティック、検尿試薬、尿分析装置、POC機器The global urinalysis market includes product type, test type, applications, and end user. A number of factors, such as the rising prevalence of kidney diseases and urinary tract infections, implementation of the Patient Protection and Affordable Care Act (PPACA) in the U.S., technological advancements, growing healthcare expenditure in various countries, and rising geriatric population are expect …
- 商業用温室の世界市場：ガラス温室、プラスチック温室、その他The global commercial greenhouse market is projected to reach USD 29.64 Billion by 2020, growing at a CAGR of 8.8% from 2015 to 2020. There have been various factors which have played a major role in driving the commercial greenhouse market across the globe. One of the major drivers is that commercial greenhouses provide higher yield compared to traditional agricultural techniques. Increasing tren …
- 世界のサプライチェーン分析：LCDテレビパネル産業As a major application for large-sized panels, LCD TV is the only end product enjoying shipment growth in 2014. Therefore, LCD TV panels have been given priority during vendors' production capacity and product specification planning. This report begins with the status of global LCD TV panel shipments, followed by an analysis of driver IC shipments, a key component for LCD TV panels, and panel vend …
- 企業向け情報アーカイビングの世界市場：Eメール、ソーシャルメディア、インスタントメッセージング、ウェブ、モバイル通信、ファイル&EFSSThe enterprise information archiving market size is expected to grow from USD 4.31 Billion in 2015 to USD 7.55 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 11.8%. The rising need for data retention to meet the legal and corporate governance requirements and improve operational efficiency has enabled wider adoption of enterprise information archiving solutions among all industries. T …
- 世界のUCaaS（Unified Communication as a service）市場動向（2012-2016）TechNavio's analysts forecast the Global Unified Communication as-a-service (UCaaS) market to grow at a CAGR of 25.46 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need for centralized management. The Global Unified Communication as-a-service (UCaaS) market has also been witnessing the adoption of cloud-based enterprise services. How …
